Choose Your News
Loading...
The O-RAN Alliance announced today that it will be releasing the first O-RAN standard Open Fronthaul Specifications comprised of control, user, ... [Read More]
Thumbnail
Last Monday, St Kitts and Nevis revealed a positive outlook for its manufacturing sector. After visiting five national plants, the Government... [Read More]
Thumbnail
Spark Connected, a leading technology developer of advanced and innovative wireless power system solutions, today announced a proprietary 30-Watt ... [Read More]
Thumbnail
HUNTINGTON BEACH, Calif. -- CiceroDx, Inc., a women's healthcare diagnostic company, is pleased to announce the publication of a pivotal study demonstrating the... [Read More]
Thumbnail
Spanish insurers are increasingly using technology to cross-sell products and target niche markets as growth opportunities domestically and abroad... [Read More]
Thumbnail
FSD Pharma Inc. ("FSD Pharma" or the "Company") (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announced today that its wholly-owned subsidiary, FV Pharma Inc.... [Read More]
Feb 19, 2019--CiceroDx, Inc., a women's healthcare diagnostic company, is pleased to announce the publication of a pivotal study demonstrating the effectiveness of both medical... [Read More]
Thumbnail
Feb 19, 2019--Spark Connected, a leading technology developer of advanced and innovative wireless power system solutions, today announced a proprietary 30-Watt wireless power solution, named... [Read More]
Thumbnail
Euromonitor International revealed the three key megatrends re-shaping the Indian market at its seminar held in Mumbai. [Read More]
Gain Therapeutics Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones. [Read More]
Gain Therapeutics SA gibt den Abschluss einer Serie-A-EU-Finanzierung in Höhe von 2,5 Millionen Euro bekannt, um neuartige hirnpenetrierende, nicht we... [Read More]
Gain Therapeutics SA annuncia la chiusura di un finanziamento di serie A da 2,5 milioni di euro per sviluppare nuovi chaperone farmacologici non compe... [Read More]
St. Bartholomew's Hospital is a key study site for CALM-2 clinical trial to explore treatment of high blood pressure. [Read More]
Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company 19 February 2019 Armadale Capital Plc ('Armadale' or 'the Company') MOU Sig... [Read More]
Feb 19, 2019--Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), an innovator in automotive vision systems, today announced that its QuadSight™ vision system was named... [Read More]
Feb 19, 2019--Accenture (NYSE: ACN) has helped Metro de Madrid develop and implement a self-learning AI-based ventilation system that minimizes energy costs and emissions and... [Read More]
Feb 19, 2019--Accenture (NYSE: ACN) has helped Metro de Madrid develop and implement a self-learning AI-based ventilation system that minimizes energy costs and emissions and... [Read More]
Zhiyun was a winner of this year's iF DESIGN AWARD, a world-renowned design prize. Each year, the world's oldest independent design organization, Hann... [Read More]
Regulatory News: ASIT biotech (BSE: ASIT) (Paris:ASIT) (Euronext: ASIT - BE0974289218), a Belgian biopharmaceutical company specialized in the researc... [Read More]
Loading...
Preview